Barbara Osband
CEO
Assay Development
Cambridge Biomedical
United States of America
Biography
From the founding of Cambridge Biomedical in 1997, Barbara recognized the need in the industry for a company that could serve as more than a provider of testing services to life sciences companies. She has consistently put into place elements that support her vision of becoming a valuable resource to our clients by providing them with unrivaled customer service built on a foundation of solid science and backed by a strong organization with consistent financial performance. Barbara received degrees from The College of New Rochelle and Sarah Lawrence College.
Research Interest
Bioanalytical services from preclinical through phase IV clinical trials, complex, custom biomarker and assay development, optimization, validation, and sample testing, laboratory testing services